| P50 | author | Youngkeun Ahn | Q87419336 |
| P2093 | author name string | Sung Soo Kim | |
| | Ju Han Kim | |
| | Jung Ha Kim | |
| | Myung Ho Jeong | |
| | Jeong Gwan Cho | |
| | Jong Chun Park | |
| | Young Joon Hong | |
| | Doo Sun Sim | |
| | Keun Ho Park | |
| | Hyun Kuk Kim | |
| | Hae Chang Jeong | |
| | Jae Yeong Cho | |
| | Dae Sung Park | |
| | Kyung Seob Lim | |
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study | Q28186001 |
| | Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function | Q28359401 |
| | Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia | Q32129328 |
| | Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol | Q33660599 |
| | Effects of combined therapy with ezetimibe plus simvastatin after drug-eluting stent implantation in a porcine coronary restenosis model | Q33807236 |
| | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model | Q37221177 |
| | Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model | Q37399625 |
| | Effects of ezetimibe on atherosclerosis in preclinical models | Q37852340 |
| | Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect | Q39883050 |
| | High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe | Q43296850 |
| | Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice | Q43822412 |
| | The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model | Q43924911 |
| | Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia | Q44264759 |
| | Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia | Q44314847 |
| | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial | Q44420382 |
| | Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial | Q45285899 |
| | Vascular protective effects of ezetimibe in ApoE-deficient mice | Q45878756 |
| | Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis | Q46427391 |
| | Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents | Q46584982 |
| | Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 |
| | Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model | Q67733219 |
| | Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction | Q71807599 |
| | Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 |
| | Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months | Q73321703 |
| | Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel | Q74711108 |
| | HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis | Q77700153 |
| | Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial | Q77933067 |
| | Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators | Q78017116 |
| | Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft | Q84711086 |
| P433 | issue | 2 | |
| P921 | main subject | coronary restenosis | Q18556246 |
| P304 | page(s) | 110-116 | |
| P577 | publication date | 2015-03-24 | |
| P1433 | published in | Korean circulation journal | Q26842331 |
| P1476 | title | Effect of pretreatment of ezetimibe/simvastatin on arterial healing and endothelialization after drug-eluting stent implantation in a porcine coronary restenosis model | |
| P478 | volume | 45 | |